Sisa dhuwit perusahaan X4 Pharmaceuticals (XFOR)

Simbol lan logo merek X4 Pharmaceuticals (XFOR)

X4 Pharmaceuticals (XFOR) is transitioning to a stage of operational cash inflow driven by sales of its orphan drug. This daily cash accumulation chart from GURU.Markets illustrates this process, where the value of 0.18 corresponds to the current metric. Professional management is effectively commercializing the WHIM therapy, although global political tensions and sanctions significantly complicate international logistics and the conduct of clinical trials.

XFOR - Dana dhuwit perusahaan X4 Pharma ing rentang 04.07.2022 - 21.11.2026

Rincian analitis perusahaan X4 Pharmaceuticals

- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian kapitalisasi pasar:
Analisis komprehensif perusahaan:X4 Pharmaceuticals, Inc XFOR
Sampel barang x4pharma.com

Investors often overestimate biotech potential while ignoring the risk of liquidity depletion during the scaling of development. By analyzing the cash balance, we assess the ability of X4 Pharmaceuticals (XFOR) to meet its obligations and fund outsourced clinical trials, where the volume of available cash serves as the primary barrier against systemic business degradation amid a high dependency on external contractors.

Analisis perusahaan pesaing

Volume dana dhuwit perusahaan ARGX|BioNTech - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan ABVX (abivax.com)|Sisa dhuwit perusahaan ADMA|Protagonist Therapeutics, Inc. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Immunovant, Inc.|KNSA: Volume dana dhuwit perusahaan|GRFS - Aset likuid perusahaan|ADPT (Adaptive Biotechnologies Inc.) - Volume dana dhuwit perusahaan|CLDX: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Aurinia Pharmaceuticals Inc. (AUPH)|Dana dhuwit perusahaan BCRX (BioCryst Pharmaceuticals Inc)|Volume dana dhuwit perusahaan VERA (Vera Corp)|Gunggung dana dhuwit perusahaan DNTH (Dianthus Therapeutics)|PHVS - Dana dhuwit perusahaan|ABCL: Dana dhuwit perusahaan|TRML: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Precigen, Inc.|Dhuwit awis perusahaan PHAR|Nektar Therapeutics - Total volume dana dhuwit perusahaan|Dana dhuwit perusahaan Upstream Bio Corp (UPB)|Dhuwit awis perusahaan Zenas Biopharma ZBIO|Dana dhuwit perusahaan Immunome Bio IMNM|GOSS: Dhuwit awis lan setara dhuwit awis perusahaan|kalvista.com - Volume dana dhuwit perusahaan|SEPN (septerna.com) - Dhuwit awis lan setara dhuwit awis perusahaan|PVLA (Pieris Pharmaceuticals) - Dhuwit awis perusahaan|Savara - Sisa dhuwit perusahaan|RIGL (Rigel Corp) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan AnaptysBio Corp|Dana dhuwit perusahaan astriatx.com (ATXS)|Dhuwit awis perusahaan enGene ENGN|Dana dhuwit perusahaan RAPT Therapeutics, Inc. RAPT|JBIO - Dhuwit awis perusahaan|Aclaris Therapeutics Inc. - Volume dana dhuwit perusahaan|KYTX - Volume dana dhuwit perusahaan|TLSA (Tiziana Life Sciences PLC) - Dhuwit awis perusahaan|cabalettabio.com (CABA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Ventyx Biosciences|THTX (Theratechnologies) - Gunggung dana dhuwit perusahaan|Dhuwit awis perusahaan AVTX (Avalo Therapeutics Inc.)|Dana dhuwit perusahaan ELDN (Eledon)|Volume dana dhuwit perusahaan AGEN (Agenus, Inc)|Aset likuid perusahaan climbbio.com (CLYM)|zurabio.com - Volume dana dhuwit perusahaan|ATYR - Volume dana dhuwit perusahaan|ADAG: Volume dana dhuwit perusahaan|Ikena Oncology, Inc. (IMA) - Volume dana dhuwit perusahaan|STTK (Shattuck Therapeutics) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan equilliumbio.com EQ|Volume dana dhuwit perusahaan CNTB|IMUX - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan Atara Biotherapeutics ATRA|Aset likuid perusahaan InflaRx N.V. (IFRX)|Adicet Bio, Inc. - Volume dana dhuwit perusahaan|CELU (celularity.com) - Dhuwit awis lan setara dhuwit awis perusahaan|INMB: Volume dana dhuwit perusahaan|Barinthus Biotherapeutics PLC (BRNS) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Kezar Life Sciences|Dhuwit awis perusahaan SAB Biotherapeutics (SABS)|Dana dhuwit perusahaan Akari Therapeutics Plc (AKTX)|Dhuwit awis perusahaan Enlivex Therapeutics, Ltd. ENLV|Q32 Bio Inc. - Dhuwit awis perusahaan|GeoVax Labs (GOVX) - Cadangan dhuwit perusahaan|edesabiotech.com - Volume dana dhuwit perusahaan|Aset likuid perusahaan iBio Corp IBIO|CARM: Volume dana dhuwit perusahaan|xtlbio.com (XTLB) - Volume dana dhuwit perusahaan|BOLT (Bolt Biotherapeutics) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan HCW Biologics (HCWB)|Dhuwit awis perusahaan APVO (Aptevo Therapeutics)|AIM - Cadangan dhuwit perusahaan|Aditxt - Dhuwit awis perusahaan|Posisi dhuwit perusahaan gribio.com|XRTX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan HIND (Vyome Holdings)|REVB (Revelation Bio) - Dhuwit awis perusahaan|Indaptus Corp (INDP) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan scinai.com|Dhuwit awis perusahaan CalciMedica, Inc. (CALI)|Dana dhuwit perusahaan Affimed NV (AFMD)|Dana dhuwit perusahaan ALLK (Allakos Inc)|Dana dhuwit perusahaan HOOKIPA Pharma, Inc. HOOK|Aset likuid perusahaan IGM Bio (IGMS)|iTeos Pharma - Volume dana dhuwit perusahaan|Aset likuid perusahaan oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan THRD